Thyroid Disease in Pregnancy: Risks and Management

How pregnancy alters thyroid function

Pregnancy places extra demands on the thyroid gland. The body needs more thyroid hormone to support the developing baby, especially in the early weeks when the fetus relies entirely on the mother’s supply. A rise in a pregnancy hormone called human chorionic gonadotropin can temporarily stimulate the thyroid, sometimes lowering TSH levels in the first trimester. At the same time, higher oestrogen levels increase the amount of binding proteins in the blood, which can change measured free hormone values.

These physiological shifts mean that laboratory reference ranges used outside pregnancy are not always appropriate. Doctors therefore rely on trimester-specific ranges whenever possible. According to the National Institute of Diabetes and Digestive and Kidney Diseases, thyroid hormones are essential for the baby’s brain and nervous system development in the first trimester. Any interpretation of blood results must take the stage of pregnancy into account and be viewed alongside symptoms and previous values.

Women who already take thyroid replacement or antithyroid medication usually need closer monitoring once pregnancy is confirmed. Dose adjustments are common because the body’s requirement for thyroid hormone typically increases. The timing and size of any change is decided by the treating clinician rather than by fixed rules applied at home.

Common thyroid conditions seen in pregnancy

Two main patterns of thyroid imbalance appear during pregnancy. Hypothyroidism occurs when the gland produces insufficient hormone. In iodine-sufficient regions this is most often linked to Hashimoto’s disease, an autoimmune process. Hyperthyroidism, in which too much hormone is made, is less common and is frequently caused by Graves’ disease. A temporary form of mild overactivity can also appear in early pregnancy, sometimes linked to severe morning sickness; this usually settles without specific treatment.

Some women enter pregnancy already diagnosed, while others develop changes that are first noticed during antenatal blood tests. Antibodies against the thyroid can cross the placenta in certain autoimmune conditions and may influence the baby’s thyroid temporarily after birth. Detailed information on underactive thyroid specifically is available in our guide to hypothyroidism in pregnancy.

Postpartum thyroiditis is a separate entity that can appear in the months after delivery. It often begins with a short phase of higher hormone levels followed by a period of lower levels. Many women recover fully, though a proportion later develop ongoing hypothyroidism. Further detail on this pattern can be found in the article on postpartum thyroiditis.

Possible effects on mother and baby

When thyroid hormone levels remain outside the range expected for pregnancy, both mother and baby may face higher chances of certain complications. Untreated or undertreated hypothyroidism has been associated with an increased likelihood of miscarriage, preterm birth, low birth weight, and, in some studies, effects on the child’s later neurodevelopment. Pre-eclampsia and postpartum haemorrhage have also been reported more frequently in some groups.

Poorly controlled hyperthyroidism carries its own set of associations, including pre-eclampsia, maternal heart strain, preterm delivery, and fetal growth restriction. In rare cases, antibodies from Graves’ disease can stimulate the baby’s thyroid. The American Thyroid Association emphasises that good control of thyroid function before and during pregnancy reduces these risks substantially for most women.

It is important to remember that an abnormal blood result is a finding that requires clinical context. Many women with mild or borderline changes experience uncomplicated pregnancies once monitored appropriately. Trends over successive tests often matter more than any single value, and personal baseline levels help the clinician decide whether a change is meaningful.

Approaches to managing underactive thyroid

The usual treatment for hypothyroidism in pregnancy is levothyroxine, a synthetic form of the hormone thyroxine. This medicine is considered safe and is the standard approach recommended by major endocrine organisations. Women already taking levothyroxine before conception are commonly advised to increase the dose once pregnancy is confirmed, because requirements rise early. The exact adjustment is individualised and guided by blood tests.

Monitoring typically involves checking TSH and free T4 at regular intervals, often every four to six weeks in the first half of pregnancy and less frequently later if stable. The aim is to keep values within the pregnancy-specific range preferred by the local laboratory and the supervising team. For more on target ranges, see our dedicated page on TSH goals in pregnancy.

Subclinical hypothyroidism (raised TSH with normal free hormone levels) is managed on a case-by-case basis. Factors such as antibody status, previous obstetric history, and the degree of TSH elevation influence whether treatment is offered. Decisions rest with the clinician after reviewing the full picture. The British Thyroid Foundation notes that prompt attention to hormone replacement supports both maternal wellbeing and fetal development.

Women should continue taking their prescribed tablets consistently, ideally on an empty stomach and separated from calcium or iron supplements that can reduce absorption. Any new symptoms such as marked fatigue, cold intolerance, or unexpected weight changes should be reported so that testing can be arranged if needed.

Approaches to managing overactive thyroid

Hyperthyroidism in pregnancy is usually managed with antithyroid medicines when treatment is required. Propylthiouracil is often preferred in the first trimester, with a possible switch to carbimazole or methimazole later, depending on local practice and individual response. The lowest effective dose is used to keep free hormone levels in the upper part of the reference range while avoiding overtreatment that could affect the baby.

Radioactive iodine is not used during pregnancy because it can harm the fetal thyroid. Surgery is reserved for selected situations where medicines cannot be tolerated or control remains difficult. Beta-blockers may be used briefly to ease symptoms such as rapid heartbeat, but longer courses are avoided when possible.

Women with a history of Graves’ disease, even if previously treated, may need antibody testing during pregnancy because TSH-receptor antibodies can persist and influence the fetus. Serial ultrasound assessment of fetal growth and heart rate is sometimes arranged when antibody levels are high or disease has been difficult to control. Additional information on this condition appears in our article on hyperthyroidism in pregnancy.

According to guidance summarised by the NICE Clinical Knowledge Summaries, specialist joint obstetric and endocrine care is recommended for most women with current or previous overt hyperthyroidism. Close liaison between the maternity team and an endocrinologist helps balance maternal control against fetal safety.

Care after birth and postpartum thyroid changes

After delivery the body’s demand for thyroid hormone usually falls. Women who increased their levothyroxine dose during pregnancy often return toward their pre-pregnancy dose, with blood tests arranged around six weeks postpartum to guide further adjustment. Those who remain on treatment continue regular monitoring.

Postpartum thyroiditis can appear within the first year after birth. It may start with a period of higher hormone levels that produces symptoms such as anxiety, palpitations, or unexplained weight loss, followed by a phase of lower levels that can cause fatigue and low mood. Many cases resolve spontaneously, although some women develop permanent hypothyroidism and need ongoing replacement. The article on postpartum thyroiditis provides a fuller discussion of recognition and follow-up.

Breastfeeding is compatible with most thyroid medicines when doses are kept within usual therapeutic ranges. Antithyroid drugs can be used at the lowest effective level, and levothyroxine is considered safe. Women with a history of postpartum thyroiditis have a higher chance of recurrence in future pregnancies and benefit from early testing if they become pregnant again.

When professional review is advisable

Any woman planning pregnancy who has a known thyroid condition should discuss optimisation of hormone levels before conception whenever possible. Once pregnant, confirmation of the pregnancy should prompt an early blood test and contact with the usual thyroid or maternity team. New symptoms that could relate to thyroid imbalance—persistent fatigue, marked heat or cold intolerance, unexplained weight change, rapid heartbeat, or tremor—warrant prompt medical assessment.

Women without a previous diagnosis may still benefit from testing if they have risk factors such as type 1 diabetes, other autoimmune disease, a family history of thyroid problems, or a history of recurrent miscarriage. Universal screening is not currently recommended in all guidelines, but targeted testing of higher-risk groups is widely supported.

Results that fall outside the expected pregnancy range, or that differ from a woman’s previous baseline, should be reviewed by a healthcare professional who can place them in clinical context. Self-adjustment of medication doses is not advised. The Royal College of Obstetricians and Gynaecologists stresses the value of coordinated care between obstetric and endocrine teams for women with significant thyroid disease.

Supporting thyroid health through pregnancy

Adequate iodine intake supports thyroid hormone production. Many prenatal vitamin preparations contain 150 micrograms of iodine, which helps meet the increased requirement during pregnancy and breastfeeding. Women who follow restricted diets or who live in areas of known iodine deficiency may need specific advice from their midwife or doctor.

Consistent tablet taking, avoidance of interacting supplements around the time of dosing, and attendance at scheduled blood tests form the practical foundation of management. Emotional support is also important; thyroid imbalance can affect mood, and open discussion with the care team helps address concerns early.

Most women with thyroid disease who receive appropriate monitoring and treatment experience pregnancies that progress normally. The combination of physiological awareness, timely laboratory assessment, and individualised medical care allows the majority of mothers and babies to do well. Ongoing communication with the healthcare team remains the safest way to navigate any changes that arise.